Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy
Open Access
- 6 April 2010
- journal article
- review article
- Published by Wiley in Immunology & Cell Biology
- Vol. 88 (4), 424-430
- https://doi.org/10.1038/icb.2010.39
Abstract
Vaccinations in medicine are commonly administered through the skin. Therefore, the vaccine is immunologically processed by antigen‐presenting cells of the skin. There is recent evidence that the clinically less often used intradermal route is effective; in cases even superior to the conventional subcutaneous or intramuscular route. Professional antigen‐presenting cells of the skin comprise epidermal Langerhans cells (CD207/langerin+), dermal langerin– and dermal langerin+ dendritic cells (DCs). In human skin, langerin– dermal DCs can be further subdivided on the basis of their reciprocal CD1a and CD14 expression. The relative contributions of these subsets to the generation of immunity or tolerance are still unclear. Langerhans cells in human skin seem to be specialized for induction of cytotoxic T lymphocytes. Likewise, mouse Langerhans cells are capable of cross‐presentation and of protecting against experimental tumours. It is desirable to harness these properties for immunotherapy. A promising strategy to dramatically improve the outcome of vaccinations is ‘antigen targeting’. Thereby, the vaccine is delivered directly and selectively to defined types of skin DCs. Targeting is achieved by means of coupling antigen to antibodies that recognize cell surface receptors on DCs. This approach is being widely explored. Little is known, however, about the events that take place in the skin and the DCs subsets involved therein. This topic will be discussed in this article.Keywords
Funding Information
- Austrian Science Fund
- National Institutes of Health (AI 13013, AI 40874, AI 057158)
This publication has 81 references indexed in Scilit:
- Langerhans cells as targets for immunotherapy against skin cancerImmunology & Cell Biology, 2010
- Dendritic cells and humoral immunity in humansImmunology & Cell Biology, 2010
- Epidermal Langerhans Cells Rapidly Capture and Present Antigens from C-Type Lectin-Targeting Antibodies Deposited in the DermisJournal of Investigative Dermatology, 2010
- Dendritic cells as controllers of antigen-specific Foxp3+ regulatory T cellsJournal of Dermatological Science, 2009
- Resident and “Inflammatory” Dendritic Cells in Human SkinJournal of Investigative Dermatology, 2009
- Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic CellsImmunity, 2008
- The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccineProceedings of the National Academy of Sciences, 2008
- Dendritic-cell immunotherapy: from ex vivo loading to in vivo targetingNature Reviews Immunology, 2007
- Production of monoclonal antibodies that recognize the extracellular domain of mouse Langerin/CD207Journal of Immunological Methods, 2007
- DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypesProceedings of the National Academy of Sciences, 2007